Light physical activity (PA) significantly improved survival in adults with chronic obstructive pulmonary disease (COPD), ...
Hong Kong-listed Sino Biopharmaceutical said on Wednesday it ​has granted AstraZeneca the ‌rights to develop a drug designed ...
The American Lung Association is announcing a new initiative to help people living with chronic obstructive pulmonary disease (COPD) better manage symptoms and improve quality of life. More than 16 ...
Shanghai: AstraZeneca will pay a subsidiary of Sino Biopharmaceutical USD 200 million upfront for the rights outside of China ...
Community Notes FRIDAY Senior Lunch — Dining hall opens at 11 a.m., Bob Chisholm Community Center, 1225 Avenue A, Seaside.
Daily voice recordings reveal early signs of asthma and COPD exacerbations, suggesting voice analysis could enhance remote ...
Dupilumab's growth is driven by its established market presence, new indications like COPD, broad multi-indication use, and strong clinical performance. Recent approvals and phase III trial successes, ...
By Andrew Silver July 8 (Reuters) - AstraZeneca will license a subsidiary of Sino Biopharmaceutical's experimental chronic ...
Clinical Trials Arena on MSN
Turn Therapeutics’ stock jumps on AD data and trial expansion
More positive Phase II data from a subgroup further supports the trial expansion, which will lead further development.
University of Manchester researchers have identified which opioids are most likely to be associated with respiratory ...
I try to run in the morning before the AQI (air quality index) gets high, specifically because I think the evening runs, when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results